呼吸照护设备的全球市场的评估:各产品类型，各适应症，各终端用户，各地区，机会，预测(2017年～2031年)

全球呼吸照护设备的市场规模，被预测从2023年的231亿5,000万美元2031年达到399亿8,000万美元，预测期间的2024年～2031年年复合成长率7.07％的成长被预料。

呼吸疾病增加，老年人口的增加，污染率的增加等，是全球呼吸照护设备市场促进因素。技术的进步，医疗的投资的增加，慢性阻塞性肺病（COPD）和气喘的流行也促进着需求。COVID-19，很强地表示了呼吸照护解决方案的呼吸补助的必要性，投资，世界的认知度。这个缘故，COVID-19大流行病期全球呼吸照护设备市场很大地增长了。

呼吸照护设备，被根据公害，高龄化，生活方式要素越发变得一般的呼吸疾病诊断，萤幕，治疗使用。对于这些的设备，人工呼吸器，吸入器，氧气浓缩机等包含，全都对在医院和家庭环境的呼吸功能的辅助和患者照护的提供来说极为重要。特别根据COVID-19大流行病，呼吸相关均衡的可靠性的高(贵)的补助的必要性被明示以来，根据呼吸系统的针对健康的意识的高涨，这些的设备的的需求也提高。携带可能容易使用的设备的技术的进步，为了连续慢性患者长期管理症状，那个利用从临床环境向家庭环境使之扩大着。呼吸照护设备，在有效管理呼吸疾病上极为重要同时，在全世界减少住院，使之提高着医疗效率。

由于通过新技术的创新改良产品的事，企业对客户来说能生出大的价值。呼吸照护设备市场成长，促进整体需求与市场扩大。譬如2024年8月，Medequip Healthcare Solutions Pvt 作为Ltd.品牌的Oxymed，SleepEasy Auto 发售了CPAP设备。该公司的组合i-series PAP也包含。i-series PAP，比预备含FlowSens演算法的最尖端科技，国际的品牌能提供的价格都对遥远便宜，舒适性大幅度提高着。这些的产品受到着CE认证，也附有品质保证。能使之提高与提供根据根据这个产品系列的扩大，印度的许多人容易的呼吸照护，客户的满意度市场上的定购数。

本报告提供全球呼吸照护设备市场相关调查分析，市场规模与预测，市场动态，提供着主要企业的形势等资讯。

目录

第1章 计划的范围和定义

第2章 调查手法

第3章 摘要整理

第4章 全球呼吸照护设备市场预测(2017年～2031年)

• 市场规模的分析与预测
  • 金额
• 市场占有率的分析与预测
  • 各产品类型
  • 各适应症
  • 各终端用户
  • 各地区
  • 市场占有率分析:各企业(金额)(前五名公司和其他 - 2023年)
• 市场地图分析(2023年)
  • 各产品类型
  • 各适应症
  • 各终端用户
  • 各地区

第5章 北美的呼吸照护设备市场预测(2017年～2031年)

• 市场规模的分析与预测
  • 金额
• 市场占有率的分析与预测
  • 各产品类型
  • 各适应症
  • 各终端用户
  • 占有率:各国
• 各国的市场评估
  • 美国的呼吸照护设备市场预测(2017年～2031年)
  • 加拿大
  • 墨西哥

第6章 欧洲的呼吸照护设备市场预测(2017年～2031年)

• 德国
• 法国
• 义大利
• 英国
• 俄罗斯
• 荷兰
• 西班牙
• 土耳其
• 波兰

第7章 亚太地区的呼吸照护设备市场预测(2017年～2031年)

• 印度
• 中国
• 日本
• 澳洲
• 越南
• 韩国
• 印尼
• 菲律宾

第8章 南美的呼吸照护设备市场预测(2017年～2031年)

• 巴西
• 阿根廷

第9章 中东·非洲的呼吸照护设备市场预测(2017年～2031年)

• 沙乌地阿拉伯
• 阿拉伯联合大公国
• 南非

第10章 供需分析

第11章 价值链分析

第12章 大环境分析

第13章 波特的五力分析

第14章 市场动态

• 推动市场要素
• 市场课题

第15章 市场趋势与发展

第16章 政策和法规形势

• 临床试验
• 法规当局的认证

第17章 价格分析

第18章 专利形势

第19章 案例研究

第20章 竞争情形

• 市场领导者前五名公司的竞争矩阵
• 前五名公司的SWOT分析
• 主要企业前十大企业的形势
  • Koninklijke Philips N.V.
  • Masimo Corp.
  • ResMed Inc.
  • Medtronic Inc.
  • GE HealthCare Technologies Inc
  • Dragerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Limited
  • Baxter International, Inc
  • Invacare International GmbH
  • Hamilton Medical AG

第21章 策略性推荐

第22章 本公司相关资料，免责声明

Global respiratory care devices market is projected to witness a CAGR of 7.07% during the forecast period 2024-2031, growing from USD 23.15 billion in 2023 to USD 39.98 billion in 2031.

The rise in respiratory diseases, the geriatric population, and increased pollution rates are some factors propelling the global respiratory care devices market. Advances in technology, rising investment in healthcare, and the prevalence of chronic obstructive pulmonary disease (COPD) as well as asthma also drive the demand. COVID-19 underlined the need for respiratory support, investments, and global awareness in respiratory care solutions. This has marked significant growth in the global respiratory care devices market during the COVID-19 pandemic.

Respiratory care devices are used to diagnose, monitor, and treat increasingly common respiratory disorders caused by pollution, aging populations, and lifestyle factors. These devices include ventilators, nebulizers, and oxygen concentrators, and they are all crucial for supporting respiratory function and delivering patient care within hospitals and home settings. Increased awareness about respiratory health has made these devices more in demand, especially since the COVID-19 pandemic highlighted the requirement for balanced and reliable support related to respiration. Technological advancements with portable, user-friendly devices expand their utilization beyond clinical settings into the home environment for chronic patients to manage symptoms over time. Respiratory care devices are pivotal in effectively managing respiratory diseases while reducing hospital admissions and improving healthcare efficiency worldwide.

Improving product offerings through the innovation of new technology makes companies create substantial value for customers. The growth of the respiratory care devices market fuels overall demand and market expansion. For instance, in August 2024, Oxymed, a brand of Medequip Healthcare Solutions Pvt Ltd., launched the SleepEasy Auto CPAP device. The company's portfolio also includes i-series PAPs; it has the most advanced technology, including the FlowSens algorithm, at significantly better comfort and at much lower prices than the international brands can offer. These products are CE-certified and accompanied by a quality warranty. This expansion in the product offerings will bring better respiratory care to more individuals in India, improving customers' satisfaction and the number of orders in the market.

Strategic Investments in Respiratory Care Devices

Strategic investments in the respiratory care devices market have been developing breakthrough technologies for personalized treatments, increasing the accuracy of diagnostics, and increasing patient compliance. Investments are made in advanced ventilators that will eventually provide a more effective management system for complicated respiratory diseases and significantly reduce complications arising from the conditions. Continuous monitoring devices critical to managing chronic respiratory diseases and those used to detect real-time changes in lung functions are also other investment areas showing large-scale focus. Besides, investments in miniaturization improve patient comfort and enable higher compliance with long-term treatments. Strategic partnerships allow innovative solutions to redefine care standards and contribute to a constantly better outcome for respiratory diseases.

For instance, in January 2023, Telesair, Inc. received Series A funding of USD 22 million from Pasaca Capital, Inc. to launch an ICU-focused Bonhawa Respiratory Humidifier in the market and design a new product to provide safer and quicker patient discharge.

Rising Air Pollution Levels Promotes the Market

The increase in air pollution levels is driving the escalation of respiratory diseases, such as asthma and breathing difficulties, thereby gaining popularity for respiratory care equipment. As a response, the government is introducing various measures to strengthen respiratory healthcare, including contributing to research in diagnostic as well as therapeutic apparatus. These measures are strengthening the respiratory care market as air pollution-linked health concerns rise, further underlining the urge for proper respiratory care solutions. For instance, in June 2024, HP Ghosh Hospital in Salt Lake City, Calcutta, launched Chest Tree, an initiative for good respiratory health. This project shows the hospital's commitment to advancing respiratory care using the most up-to-date technology and specialized medical staff. The Chest Tree visually maps all types of respiratory conditions, including COPD, asthma, lung cancer, and other sleep disorders, for easier comprehension of the facilities offered. This thus allows patients to better engage with and understand the treatment options, thereby upgrading awareness.

Rising Awareness of Respiratory Care

With the growing awareness of respiratory health issues, more people are now focusing on their respiratory well-being; hence, there is an increasing demand for respiratory care devices. Nowadays, people are more conscious of air pollution's impact on their lives, leading to more adoption of products like portable oxygen concentrators and non-invasive ventilators. Therefore, growing awareness is driving the market further towards innovation in home-care solutions as consumers look for easily accessible solutions with friendlier interfaces that can help them cope with asthma. Considering this increased demand for effective personalized respiratory care solutions, manufacturers are innovating to expand their offerings.

For instance, in May 2023, Cipla Limited introduced the 'Tuffies' campaign to increase awareness of respiratory care in children across India, especially patient groups with asthma. This would influence the market for respiratory care devices with increased awareness and demand for effective solutions for asthma management in children. Moreover, in October 2022, AirPhysio Pty Ltd partnered with Apollo Hospitals Group and Medsmart and launched its respiratory devices in India. This partnership is set to increase the awareness and demand for these innovative products in India.

COPD Application Segment to Lead the Growth of Market Due to Rising Patient Population

The COPD segment leads in the market for respiratory care devices primarily due to the increased incidence of chronic obstructive pulmonary disease. Improvement in technology and continuous innovation ensures the development of advanced devices to improve patient results. Partnerships of leading healthcare companies with device manufacturers promote this trend, thus providing a boost to the development and distribution of innovative solutions. Such efforts result in higher adoption of respiratory care devices for COPD. The strategic focus on COPD management becomes one of the key drivers for market growth and addresses the needs of patients with such conditions.

For instance, in March 2023, the University of California, Davis, in collaboration with Propeller Health, launched a remote monitoring program for patients. The program consists of sensors, a mobile app, and personalized support to track medication usage and respiration, which might then be integrated with UC Davis's electronic health records for enhanced patient care. The program can be expanded to other health systems under the University of California, enhancing chronic disease management, especially COPD.

North America to be in the Dominating Region

North America leads the global respiratory care devices market due to a combination of factors. The high prevalence of respiratory conditions like asthma, COPD, and even sleep apnea in the region is a major factor driving demand for more advanced respiratory devices. Based on CDC data published in 2023, asthma affects 7.7% of Americans and is more prevalent in adults, at 8.0%, and females at 9.7%. Of the reported 24.9 million affected, 60% of the adults and 44% of the children experience uncontrolled asthma. In addition, an increasing awareness of respiratory health issues through various organizations and government efforts has further led to expanding this market. In the United States, a program called "Healthy People 2030, "initiated by the U.S. Department of Health and Human Services, promotes respiratory health. The emergence of key regional players further hastens the innovation and accessibility of advanced devices. In addition, the well-established healthcare infrastructure, growing healthcare expenditures, and rising adoption of home healthcare solutions in North America further favor the region's leadership in the global marketplace.

Future Market Scenario (2024-2031F)

Key drivers for future growth in respiratory care devices are the growing incidence of chronic respiratory diseases, advancements in technology, and the need for home healthcare solutions. Advancements in miniaturization of devices and integration into the digital health platform will expand patient availability, further propelling market growth.

In October 2024, Inspira-Technologies OXY B.H.N. LTD. introduced disposable blood oxygenation kit for all types of life support machines compatible with INSPIRA ART devices.

This innovation will help boost the efficiency of hospitals in maintaining compatibility with cardio-pulmonary bypass machines. This launch is expected to spur growth in the respiratory care devices market by providing cost-effective and versatile solutions for better patient care.

In April 2023, OxyGo HQ Florida, LLC launched a new product for the portable oxygen concentrator, the OxyHome 5L Stationary Concentrator, which is aptly designed to provide constant flow with up to 5L per minute. This oxygen supply is highly recommended for home use. The launch would have a significant impact on the market for respiratory care devices, increasing readily available home-based oxygen therapy options and therefore demand for convenient and user-friendly respiratory solutions in the next few years.

Key Players Landscape and Outlook

Companies have been productively tailoring services to the specific needs and preferences of patients to build up market positions. They are integrating advanced technologies such as AI and IoT to improve efficiency regarding devices as well as outcomes for patients. Another strategy is to enter new international markets to enhance the base of customers. Companies associate themselves with healthcare providers and technology firms through collaborative partnerships in innovation and wider offerings. These strategies help firms increase their market reach and drive growth in the forecast period.

In February 2024, ResMed Inc launched in the United States AirCurve 11 branded series of bilevel-positive airway pressure devices. Bilevel machines, utilizing the AirSense 11 platform, are designed to help move patients with difficulties using CPAP to other comfort and convenience devices. The AirCurve 11 VAuto responds to the patient's breathing patterns with comfort that will produce better compliance of the patient. With Philips having exited the market because of the massive recall, ResMed will face an even firmer grip on the respiratory care device market through superior and reliable solutions.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Respiratory Care Devices Market Outlook, 2017-2031F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product Type
    • 4.2.1.1. Therapeutic Devices
      • 4.2.1.1.1. Ventilators
      • 4.2.1.1.2. Nebulizers
      • 4.2.1.1.3. Oxygen Concentrators
      • 4.2.1.1.4. Inhalers
    • 4.2.1.2. Monitoring Devices
      • 4.2.1.2.1. Pulse Oximeters
      • 4.2.1.2.2. Capnography
      • 4.2.1.2.3. Gas Analyzers
    • 4.2.1.3. Diagnostic Devices
      • 4.2.1.3.1. Spirometers
      • 4.2.1.3.2. Polysomnography Devices
    • 4.2.1.4. Consumables & Accessories
      • 4.2.1.4.1. Masks
      • 4.2.1.4.2. Tracheostomy Tubes
      • 4.2.1.4.3. Nasal Cannulae
  • 4.2.2. By Disease Indications
    • 4.2.2.1. Chronic Obstructive Pulmonary Disease (COPD)
    • 4.2.2.2. Asthma
    • 4.2.2.3. Sleep Apnea
    • 4.2.2.4. Infectious Diseases
    • 4.2.2.5. Others
  • 4.2.3. By End-user
    • 4.2.3.1. Hospitals
    • 4.2.3.2. Home Care Settings
    • 4.2.3.3. Ambulatory Care Centers
    • 4.2.3.4. Others
  • 4.2.4. By Region
    • 4.2.4.1. North America
    • 4.2.4.2. Europe
    • 4.2.4.3. Asia-Pacific
    • 4.2.4.4. South America
    • 4.2.4.5. Middle East and Africa
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
• 4.3. Market Map Analysis, 2023
  • 4.3.1. By Product Type
  • 4.3.2. By Disease Indications
  • 4.3.3. By End-user
  • 4.3.4. By Region

5. North America Respiratory Care Devices Market Outlook, 2017-2031F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product Type
    • 5.2.1.1. Therapeutic Devices
      • 5.2.1.1.1. Ventilators
      • 5.2.1.1.2. Nebulizers
      • 5.2.1.1.3. Oxygen Concentrators
      • 5.2.1.1.4. Inhalers
    • 5.2.1.2. Monitoring Devices
      • 5.2.1.2.1. Pulse Oximeters
      • 5.2.1.2.2. Capnography
      • 5.2.1.2.3. Gas Analyzers
    • 5.2.1.3. Diagnostic Devices
      • 5.2.1.3.1. Spirometers
      • 5.2.1.3.2. Polysomnography Devices
    • 5.2.1.4. Consumables & Accessories
      • 5.2.1.4.1. Masks
      • 5.2.1.4.2. Tracheostomy Tubes
      • 5.2.1.4.3. Nasal Cannulae
  • 5.2.2. By Disease Indications
    • 5.2.2.1. Chronic Obstructive Pulmonary Disease (COPD)
    • 5.2.2.2. Asthma
    • 5.2.2.3. Sleep Apnea
    • 5.2.2.4. Infectious Diseases
    • 5.2.2.5. Others
  • 5.2.3. By End-user
    • 5.2.3.1. Hospitals
    • 5.2.3.2. Home Care Settings
    • 5.2.3.3. Ambulatory Care Centers
    • 5.2.3.4. Others
  • 5.2.4. By Country Share
    • 5.2.4.1. United States
    • 5.2.4.2. Canada
    • 5.2.4.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Respiratory Care Devices Market Outlook, 2017-2031F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Product Type
        • 5.3.1.2.1.1. Therapeutic Devices
        • 5.3.1.2.1.1.1. Ventilators
        • 5.3.1.2.1.1.2. Nebulizers
        • 5.3.1.2.1.1.3. Oxygen Concentrators
        • 5.3.1.2.1.1.4. Inhalers
        • 5.3.1.2.1.2. Monitoring Devices
        • 5.3.1.2.1.2.1. Pulse Oximeters
        • 5.3.1.2.1.2.2. Capnography
        • 5.3.1.2.1.2.3. Gas Analyzers
        • 5.3.1.2.1.3. Diagnostic Devices
        • 5.3.1.2.1.3.1. Spirometers
        • 5.3.1.2.1.3.2. Polysomnography Devices
        • 5.3.1.2.1.4. Consumables & Accessories
        • 5.3.1.2.1.4.1. Masks
        • 5.3.1.2.1.4.2. Tracheostomy Tubes
        • 5.3.1.2.1.4.3. Nasal Cannulae
      • 5.3.1.2.2. By Disease Indications
        • 5.3.1.2.2.1. Chronic Obstructive Pulmonary Disease (COPD)
        • 5.3.1.2.2.2. Asthma
        • 5.3.1.2.2.3. Sleep Apnea
        • 5.3.1.2.2.4. Infectious Diseases
        • 5.3.1.2.2.5. Others
      • 5.3.1.2.3. By End-user
        • 5.3.1.2.3.1. Hospitals
        • 5.3.1.2.3.2. Home Care Settings
        • 5.3.1.2.3.3. Ambulatory Care Centers
        • 5.3.1.2.3.4. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Respiratory Care Devices Market Outlook, 2017-2031F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Turkey
• 6.9. Poland

7. Asia-Pacific Respiratory Care Devices Market Outlook, 2017-2031F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America Respiratory Care Devices Market Outlook, 2017-2031F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa Respiratory Care Devices Market Outlook, 2017-2031F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa

10. Demand Supply Analysis

11. Value Chain Analysis

12. PESTLE Analysis

13. Porter's Five Forces Analysis

14. Market Dynamics

• 14.1. Market Drivers
• 14.2. Market Challenges

15. Market Trends and Developments

16. Policy And Regulatory Landscape

• 16.1. Clinical Trials
• 16.2. Regulatory Approvals

17. Pricing Analysis

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

• 20.1. Competition Matrix of Top 5 Market Leaders
• 20.2. SWOT Analysis for Top 5 Players
• 20.3. Key Players Landscape for Top 10 Market Players
  • 20.3.1. Koninklijke Philips N.V.
    • 20.3.1.1. Company Details
    • 20.3.1.2. Key Management Personnel
    • 20.3.1.3. Products and Services
    • 20.3.1.4. Financials (As Reported)
    • 20.3.1.5. Key Market Focus and Geographical Presence
    • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 20.3.2. Masimo Corp.
  • 20.3.3. ResMed Inc.
  • 20.3.4. Medtronic Inc.
  • 20.3.5. GE HealthCare Technologies Inc
  • 20.3.6. Dragerwerk AG & Co. KGaA
  • 20.3.7. Fisher & Paykel Healthcare Limited
  • 20.3.8. Baxter International, Inc
  • 20.3.9. Invacare International GmbH
  • 20.3.10. Hamilton Medical AG

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 2. Global Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 3. Global Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 4. Global Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 5. Global Respiratory Care Devices Market Share (%), By Region, 2017-2031F
• Figure 6. North America Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 7. North America Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 8. North America Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 9. North America Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 10. North America Respiratory Care Devices Market Share (%), By Country, 2017-2031F
• Figure 11. United States Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 12. United States Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 13. United States Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 14. United States Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 15. Canada Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 16. Canada Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 17. Canada Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 18. Canada Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 19. Mexico Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 20. Mexico Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 21. Mexico Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 22. Mexico Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 23. Europe Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 24. Europe Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 25. Europe Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 26. Europe Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 27. Europe Respiratory Care Devices Market Share (%), By Country, 2017-2031F
• Figure 28. Germany Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 29. Germany Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 30. Germany Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 31. Germany Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 32. France Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 33. France Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 34. France Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 35. France Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 36. Italy Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 37. Italy Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 38. Italy Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 39. Italy Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 40. United Kingdom Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 41. United Kingdom Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 42. United Kingdom Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 43. United Kingdom Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 44. Russia Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 45. Russia Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 46. Russia Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 47. Russia Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 48. Netherlands Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 49. Netherlands Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 50. Netherlands Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 51. Netherlands Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 52. Spain Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 53. Spain Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 54. Spain Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 55. Spain Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 56. Turkey Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 57. Turkey Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 58. Turkey Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 59. Turkey Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 60. Poland Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 61. Poland Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 62. Poland Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 63. Poland Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 64. South America Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 65. South America Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 66. South America Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 67. South America Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 68. South America Respiratory Care Devices Market Share (%), By Country, 2017-2031F
• Figure 69. Brazil Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 70. Brazil Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 71. Brazil Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 72. Brazil Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 73. Argentina Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 74. Argentina Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 75. Argentina Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 76. Argentina Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 77. Asia-Pacific Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 78. Asia-Pacific Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 79. Asia-Pacific Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 80. Asia-Pacific Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 81. Asia-Pacific Respiratory Care Devices Market Share (%), By Country, 2017-2031F
• Figure 82. India Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 83. India Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 84. India Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 85. India Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 86. China Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 87. China Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 88. China Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 89. China Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 90. Japan Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 91. Japan Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 92. Japan Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 93. Japan Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 94. Australia Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 95. Australia Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 96. Australia Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 97. Australia Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 98. Vietnam Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 99. Vietnam Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 100. Vietnam Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 101. Vietnam Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 102. South Korea Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 103. South Korea Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 104. South Korea Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 105. South Korea Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 106. Indonesia Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 107. Indonesia Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 108. Indonesia Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 109. Indonesia Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 110. Philippines Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 111. Philippines Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 112. Philippines Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 113. Philippines Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 114. Middle East & Africa Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 115. Middle East & Africa Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 116. Middle East & Africa Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 117. Middle East & Africa Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 118. Middle East & Africa Respiratory Care Devices Market Share (%), By Country, 2017-2031F
• Figure 119. Saudi Arabia Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 120. Saudi Arabia Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 121. Saudi Arabia Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 122. Saudi Arabia Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 123. UAE Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 124. UAE Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 125. UAE Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 126. UAE Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 127. South Africa Respiratory Care Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 128. South Africa Respiratory Care Devices Market Share (%), By Product Type, 2017-2031F
• Figure 129. South Africa Respiratory Care Devices Market Share (%), By Disease Indications, 2017-2031F
• Figure 130. South Africa Respiratory Care Devices Market Share (%), By End-user, 2017-2031F
• Figure 131. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 132. By Disease Indications Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023